check_circleStudy Completed

Migraine

Nimodipine (Bay e 9736) in migraine prophylaxis

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

17 - 52 Years
  • -

  • -

Trial summary

Enrollment Goal
25
Trial Dates
March 1980 - August 1980
Phase
Phase 4
Could I Receive a placebo
N/A
Products
Nimotop (Nimodipine, BAYE9736)
Accepts Healthy Volunteer
N/A

Trial design

Test of the effectiveness and tolerance of nimodipine (Bay e 9736) in migraine prophylaxis.
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
Treatment
Allocation
N/A
Blinding
N/A
Assignment
Single Group Assignment
Trial Arms
N/A